Rejuvenating neural networks
Kaliko is an early-stage biotech platform at the forefront of longevity therapeutics. Our mission is to redefine the process and experience of aging by developing the most effective treatments for neuropsychiatric and neurological conditions.
Unlocking the future of brain health
At Kaliko, we harness the power of cutting-edge technology and rigorous scientific research to drive innovation in longevity therapeutics. Our approach combines advanced computational techniques with preclinical studies to identify and develop novel chemical compounds that target key receptors and pathways involved in neuro-genesis, plasticity, inflammation, and protection.
By prioritizing the brain's health, our mission is to create therapies that not only improve cognitive function and mental well-being but also have far-reaching benefits for disease prevention and treatment. Our rigorous methodology is aimed at bringing the safest and most effective treatments to market, with the potential to revolutionize aging.
Leveraging Global Knowledge, Powering Innovation
Kaliko is proud to announce a strategic partnership with Malia. Together, we combine our expertise and resources to develop and commercialize groundbreaking neurotherapeutics. This collaboration underscores our commitment to address unmet medical needs and meaningfully impact the lives of people around the world.